# Nuformix Secures Key Patents and Outlines Future Plans for NXP002 and NXP004 (VIDEO)

- Link: https://www.directorstalkinterviews.com/nuformix-secures-key-patents-and-outlines-future-plans-for-nxp002-and-nxp004-video/4121160642
- Published: 2024-06-18T07:42:13+01:00
- Author: Ethan Davis

**Nuformix Plc** ([LON:NFX](https://www.directorstalkinterviews.com/company/nuformix-plc/nfx.l)),
a pharmaceutical development company focused on drug repurposing for fibrosis and
oncology, recently provided a patent update for its NXP002 and NXP004 programs, 
as well as its interim results.

In this interview with Nuformix Executive Director Dr. Dan Gooding, the discussion
covers the significance of these patents in advancing their programs, particularly
NXP002, which is aimed at treating lung fibrosis with an inhaled therapy. The update
also highlights the company’s lean management approach and ongoing efforts to secure
development partners. Dan outlines the next steps for Nuformix, emphasising their
commitment to progressing their drug programs and finding suitable partners for 
further development.

Share on:
